Our primary aim of the proposed study is to document the efficacy of Behavioral Activation (BA) in the acute treatment of major depressive disorder (MDD), by comparing it to cognitive therapy (CT), Sertraline, and pill placebo (PLA).
A second aim i s to test the significance of the interaction between severity of MDD and response to pharmacological versus psychosocial treatments.
A third aim i s to determine whether or not BA and CT can prevent depressive relapse, by comparing these treatments during continuation and follow-up phases to a control group of subjects brought to remission with Sertraline and then switched to a placebo (SRD) after 16 weeks of acute treatment.
A final aim i s to examine the relapse prevention potential of BA and CT compared to a state-of-the-art, drug continuation regimen (SRC) for treatment responders. Our predictors are that both psychotherapies - CT and BA - as well as Sertraline will be more effective than PLA for the more severely depressed outpatients, but that the three active treatments will not be differentially effective at the end of acute treatment. At all follow-up points in time, we expect both psychotherapies - BA and CT - and SRC to be more effective at preventing relapse than SRD subjects. The implications for mental health policy are significant. Currently, pharmacotherapy constitutes the """"""""gold standard"""""""" for maximizing the likelihood of acute treatment response. However, none of the pharmacotherapies are curative. If either BA, CT, or both prevent relapse, subjects with depression have treatment options, and medical costs may be significantly reduced. In particular, if BA, an extremely parismonious treatment, is not significantly less effective than CT after either 16 weeks of acute treatment response or at preventing relapse, we will have provided strong support that depressives can be maintained without medication at minimal costs. BA should be relatively easy to teach paraprofessional therapists, and perhaps can even be adapted to a self-administered format, because its intervention options are few, and the decision rules for implementation of particular interventions are straightforward.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH055502-02
Application #
2675461
Study Section
Treatment Assessment Review Committee (TA)
Project Start
1997-06-25
Project End
2002-03-31
Budget Start
1998-05-15
Budget End
1999-03-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Webb, Christian A; Derubeis, Robert J; Hollon, Steven D et al. (2013) Convergence and divergence in the delivery of cognitive therapy in two randomized clinical trials. Behav Res Ther 51:493-8
Webb, Christian A; Derubeis, Robert J; Dimidjian, Sona et al. (2012) Predictors of patient cognitive therapy skills and symptom change in two randomized clinical trials: the role of therapist adherence and the therapeutic alliance. J Consult Clin Psychol 80:373-81
Webb, Christian A; DeRubeis, Robert J; Amsterdam, Jay D et al. (2011) Two aspects of the therapeutic alliance: differential relations with depressive symptom change. J Consult Clin Psychol 79:279-83
Kwan, Bethany M; Dimidjian, Sona; Rizvi, Shireen L (2010) Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther 48:799-804
Dobson, Keith S; Hollon, Steven D; Dimidjian, Sona et al. (2008) Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 76:468-77
Coffman, Sandra J; Martell, Christopher R; Dimidjian, Sona et al. (2007) Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? J Consult Clin Psychol 75:531-41
Dimidjian, Sona; Hollon, Steven D; Dobson, Keith S et al. (2006) Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 74:658-70